BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27231235)

  • 1. Farnesiferol c induces apoptosis via regulation of L11 and c-Myc with combinational potential with anticancer drugs in non-small-cell lung cancers.
    Jung JH; Kim MJ; Lee H; Lee J; Kim J; Lee HJ; Shin EA; Kim YH; Kim B; Shim BS; Kim SH
    Sci Rep; 2016 May; 6():26844. PubMed ID: 27231235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colocalization of MID1IP1 and c-Myc is Critically Involved in Liver Cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2.
    Jung JH; Lee HJ; Kim JH; Sim DY; Im E; Kim S; Chang S; Kim SH
    Cells; 2020 Apr; 9(4):. PubMed ID: 32316188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribosomal protein L5 mediated inhibition of c-Myc is critically involved in sanggenon G induced apoptosis in non-small lung cancer cells.
    Park JE; Jung JH; Lee HJ; Sim DY; Im E; Park WY; Shim BS; Ko SG; Kim SH
    Phytother Res; 2021 Feb; 35(2):1080-1088. PubMed ID: 32935429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteoloside induces G
    Zhou M; Shen S; Zhao X; Gong X
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer effect of the water extract of a commercial Spirulina (Arthrospira platensis) product on the human lung cancer A549 cell line.
    Czerwonka A; Kaławaj K; Sławińska-Brych A; Lemieszek MK; Bartnik M; Wojtanowski KK; Zdzisińska B; Rzeski W
    Biomed Pharmacother; 2018 Oct; 106():292-302. PubMed ID: 29966973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reevesioside A, a cardenolide glycoside, induces anticancer activity against human hormone-refractory prostate cancers through suppression of c-myc expression and induction of G1 arrest of the cell cycle.
    Leu WJ; Chang HS; Chan SH; Hsu JL; Yu CC; Hsu LC; Chen IS; Guh JH
    PLoS One; 2014; 9(1):e87323. PubMed ID: 24475272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas.
    Zhang X; Teng Y; Yang F; Wang M; Hong X; Ye LG; Gao YN; Chen GY
    Oncol Rep; 2015 May; 33(5):2599-605. PubMed ID: 25738322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginkgetin induces apoptosis via activation of caspase and inhibition of survival genes in PC-3 prostate cancer cells.
    You OH; Kim SH; Kim B; Sohn EJ; Lee HJ; Shim BS; Yun M; Kwon BM; Kim SH
    Bioorg Med Chem Lett; 2013 May; 23(9):2692-5. PubMed ID: 23523142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Metastatic Effect of Dehydrocorydaline on H1299 Non-Small Cell Lung Carcinoma Cells via Inhibition of Matrix Metalloproteinases and B Cell Lymphoma 2.
    Lee J; Sohn EJ; Yoon SW; Kim CG; Lee S; Kim JY; Baek N; Kim SH
    Phytother Res; 2017 Mar; 31(3):441-448. PubMed ID: 28144994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bufalin induces G0/G1 phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells.
    Huang WW; Yang JS; Pai SJ; Wu PP; Chang SJ; Chueh FS; Fan MJ; Chiou SM; Kuo HM; Yeh CC; Chen PY; Tsuzuki M; Chung JG
    Mutat Res; 2012 Apr; 732(1-2):26-33. PubMed ID: 22285700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of caspases and inhibition of ribosome biogenesis mediate antitumor activity of Chijongdan in A549 non-small lung cancer cells.
    Kim BG; Kwon HY; Sohn EJ; Hwang S; Kwon OS; Kim SH
    BMC Complement Altern Med; 2014 Oct; 14():420. PubMed ID: 25345917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
    Song J; Ko HS; Sohn EJ; Kim B; Kim JH; Kim HJ; Kim C; Kim JE; Kim SH
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1188-91. PubMed ID: 24461294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of PHRF1 attenuates the proliferation and tumorigenicity of non-small cell lung cancer cells.
    Wang Y; Wang H; Pan T; Li L; Li J; Yang H
    Oncotarget; 2016 Sep; 7(39):64360-64370. PubMed ID: 27608840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer effects of ginsenoside Rk3 on non-small cell lung cancer cells: in vitro and in vivo.
    Duan Z; Deng J; Dong Y; Zhu C; Li W; Fan D
    Food Funct; 2017 Oct; 8(10):3723-3736. PubMed ID: 28949353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
    Hsiao CJ; Hsiao G; Chen WL; Wang SW; Chiang CP; Liu LY; Guh JH; Lee TH; Chung CL
    J Nat Prod; 2014 Apr; 77(4):758-65. PubMed ID: 24588135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Casticin induces caspase-mediated apoptosis via activation of mitochondrial pathway and upregulation of DR5 in human lung cancer cells.
    Zhou Y; Peng Y; Mao QQ; Li X; Chen MW; Su J; Tian L; Mao NQ; Long LZ; Quan MF; Liu F; Zhou SF; Zhao YX
    Asian Pac J Trop Med; 2013 May; 6(5):372-8. PubMed ID: 23608376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Signaling Pathways Involved in the Anti-proliferative and Apoptosis-inducing Effects of M22 against Non-small Cell Lung Adenocarcinoma A549 Cells.
    Yuan Y; Wu J; Li B; Niu J; Tan H; Qiu S
    Sci Rep; 2018 Jan; 8(1):992. PubMed ID: 29343765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer.
    Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS
    J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways.
    Leu WJ; Swain ShP; Chan SH; Hsu JL; Liu SP; Chan ML; Yu CC; Hsu LC; Chou YL; Chang WL; Hou DR; Guh JH
    Oncotarget; 2016 Nov; 7(47):76995-77009. PubMed ID: 27769069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin A but not cyclin D1 is essential for c-myc-modulated cell-cycle progression.
    Qi Y; Tu Y; Yang D; Chen Q; Xiao J; Chen Y; Fu J; Xiao X; Zhou Z
    J Cell Physiol; 2007 Jan; 210(1):63-71. PubMed ID: 17013808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.